Search Results 1031-1040 of 18361 for Hepatitis b
Hepatitis B or C virus infection; Primary sclerosing cholangitis; Alcoholic liver disease; Definite autoimmune liver disease or overlap hepatitis; Nonalcoholic ...
The purpose of this study is to prospectively define the incidence of new and/or worsening hypertension in patients with B-cell malignancies on Bruton Tyrosine ...
Because the vaccine has trace amounts of the antibiotics streptomycin, polymyxin B and neomycin, it may cause a reaction in people allergic to one of these ...
Evidence of active or latent Human immunodeficiency virus (HIV), Hepatitis B or Hepatitis C, or tuberculosis (TB) infection at Screening. 20. Prior ...
Detectible Hepatitis B Virus (HBV) DNA within 10 days prior to darTreg infusion. Detectable circulating HCV RNA within 10 days prior to darTreg infusion ...
Known active hepatitis B (e.g., hepatitis B surface antigen [HBsAg] reactive) or hepatitis C (e.g., hepatitis C virus [HCV] ribonucleic acid RNA [qualitative] ...
Subject has historical or active infection with hepatitis B, or hepatitis C. Subject is pregnant or breast-feeding. Subject is currently enrolled in any ...
... hepatitis B surface antigen (HBsAg) (hepatitis B virus [HBV] surface antigen). Patients known to be human immunodeficiency virus (HIV) positive, except ...
... hepatitis C virus (HCV), hepatitis B virus (HBV), as determined by serologic tests. 9. Known history of infection with human immunodeficiency virus (HIV) ...
Hepatitis and fibrosis more likely related to etiologies other than ... History of hepatitis B and/or hepatitis C. History of malignancy. Exceptions ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.